Table 1.
Target coverage metrics and OAR doses
| Structures | Parameters | Halcyon | Trilogy | z | p | |
|---|---|---|---|---|---|---|
| PTV | D2%(Gy) | 54.86±0.16 | 54.73±0.34 | -2.36 | 0.190 | |
| D98%(Gy) | 50.35±0.42 | 50.25±0.59 | -0.57 | 0.573 | ||
| HI | 0.09±0.01 | 0.09±0.02 | -0.47 | 0.645 | ||
| CI | 0.81±0.04 | 0.83±0.03 | -3.05 | 0.206 | ||
| GI | 5.05±0.84 | 5.06±0.79 | -0.29 | 0.773 | ||
| OAR | Bladder | V20(%) | 83.14±8.54 | 88.01±7.21 | -0.23 | 0.822 |
| V30(%) | 46.25±9.10 | 54.87±8.95 | -2.20 | 0.028 | ||
| V40(%) | 24.37±6.87 | 28.41±7.62 | -3.34 | 0.001 | ||
| Dmean(Gy) | 31.04±2.57 | 32.83±2.26 | -1.27 | 0.081 | ||
| Rectum | V20(%) | 86.72±11.32 | 92.91±5.58 | -2.02 | 0.044 | |
| V30(%) | 42.35±12.38 | 58.26±9.76 | -4.47 | 0.001 | ||
| V40(%) | 19.05±8.62 | 22.94±9.40 | -1.46 | 0.146 | ||
| Dmean(Gy) | 30.13±3.13 | 32.78±2.30 | -3.23 | 0.001 | ||
| Femoral Head_L | V20(%) | 29.00±9.49 | 44.30±13.20 | -4.43 | 0.000 | |
| V30(%) | 6.81±3.84 | 12.21±8.71 | -2.84 | 0.005 | ||
| V40(%) | 0.41±0.89 | 0.96±1.62 | -2.27 | 0.023 | ||
| Dmean(Gy) | 17.18±2.20 | 20.45±2.46 | -4.53 | 0.000 | ||
| Femoral Head_R | V20(%) | 30.30±9.13 | 43.95±11.40 | -4.44 | 0.000 | |
| V30(%) | 8.39±4.5 | 10.91±9.12 | 0.56 | 0.575 | ||
| V40(%) | 1.11±1.41 | 0.71±1.72 | -2.08 | 0. 370 | ||
| Dmean(Gy) | 17.57±2.24 | 20.22±2.16 | -3.91 | 0.000 | ||
| Normal Tissue | V5(%) Dmean(Gy) |
51.24±8.63 11.58±1.86 |
51.86±7.78 11.53±1.67 |
-0.699 -0.118 |
0.440 0.85 |
|